Inspire Investing LLC Sells 17,095 Shares of HealthEquity, Inc. (NASDAQ:HQY)

Inspire Investing LLC lowered its position in HealthEquity, Inc. (NASDAQ:HQY) by 71.1% in the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 6,932 shares of the company’s stock after selling 17,095 shares during the period. Inspire Investing LLC’s holdings in HealthEquity were worth $665,000 as of its most recent SEC filing.

Other large investors have also made changes to their positions in the company. Raymond James Trust N.A. boosted its stake in HealthEquity by 4.8% in the 3rd quarter. Raymond James Trust N.A. now owns 2,905 shares of the company’s stock worth $238,000 after purchasing an additional 132 shares during the period. UMB Bank n.a. boosted its stake in HealthEquity by 65.6% in the 4th quarter. UMB Bank n.a. now owns 414 shares of the company’s stock worth $40,000 after purchasing an additional 164 shares during the period. Truist Financial Corp boosted its stake in HealthEquity by 7.0% in the 2nd quarter. Truist Financial Corp now owns 2,864 shares of the company’s stock worth $247,000 after purchasing an additional 188 shares during the period. Elk River Wealth Management LLC boosted its stake in HealthEquity by 0.3% in the 3rd quarter. Elk River Wealth Management LLC now owns 66,181 shares of the company’s stock worth $5,417,000 after purchasing an additional 217 shares during the period. Finally, Nicolet Advisory Services LLC boosted its stake in HealthEquity by 5.8% in the 3rd quarter. Nicolet Advisory Services LLC now owns 4,218 shares of the company’s stock worth $330,000 after purchasing an additional 233 shares during the period. Institutional investors own 99.55% of the company’s stock.

Analyst Upgrades and Downgrades

A number of brokerages recently weighed in on HQY. Royal Bank of Canada upped their target price on shares of HealthEquity from $100.00 to $105.00 and gave the stock an “outperform” rating in a research note on Tuesday, December 10th. Barrington Research upped their target price on shares of HealthEquity from $105.00 to $120.00 and gave the stock an “outperform” rating in a research note on Monday, December 2nd. Bank of America increased their price objective on shares of HealthEquity from $100.00 to $120.00 and gave the stock a “buy” rating in a research note on Wednesday, November 13th. BTIG Research increased their price objective on shares of HealthEquity from $110.00 to $130.00 and gave the stock a “buy” rating in a research note on Thursday, November 14th. Finally, Mizuho began coverage on shares of HealthEquity in a research note on Wednesday, December 4th. They set an “outperform” rating and a $126.00 price objective for the company. One equities research analyst has rated the stock with a hold rating and thirteen have given a buy rating to the stock. Based on data from MarketBeat.com, HealthEquity presently has an average rating of “Moderate Buy” and an average target price of $110.71.

HealthEquity Stock Up 2.1 %

Shares of HQY stock opened at $106.88 on Friday. The company has a debt-to-equity ratio of 0.51, a quick ratio of 3.20 and a current ratio of 3.20. The firm’s 50-day moving average is $99.60 and its 200-day moving average is $87.35. The stock has a market cap of $9.26 billion, a price-to-earnings ratio of 98.06, a PEG ratio of 1.86 and a beta of 0.54. HealthEquity, Inc. has a 52-week low of $65.01 and a 52-week high of $107.87.

HealthEquity (NASDAQ:HQY) last issued its earnings results on Monday, December 9th. The company reported $0.59 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.71 by ($0.12). HealthEquity had a net margin of 8.41% and a return on equity of 9.70%. During the same quarter in the prior year, the firm earned $0.40 earnings per share. Sell-side analysts predict that HealthEquity, Inc. will post 2.32 EPS for the current year.

Insider Activity

In other HealthEquity news, Director Frank Corvino sold 1,039 shares of the stock in a transaction dated Wednesday, November 6th. The shares were sold at an average price of $96.10, for a total value of $99,847.90. Following the transaction, the director now directly owns 3,784 shares of the company’s stock, valued at $363,642.40. This represents a 21.54 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, Director Stuart B. Parker sold 25,000 shares of the stock in a transaction dated Thursday, December 12th. The shares were sold at an average price of $96.72, for a total transaction of $2,418,000.00. Following the completion of the transaction, the director now directly owns 19,061 shares in the company, valued at approximately $1,843,579.92. This represents a 56.74 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 34,289 shares of company stock valued at $3,355,718. 2.20% of the stock is owned by company insiders.

HealthEquity Company Profile

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.